145 related articles for article (PubMed ID: 25851596)
1. Identification of Commonly Dysregulated Genes in Non-small-cell Lung Cancer by Integrated Analysis of Microarray Data and qRT-PCR Validation.
Tian ZQ; Li ZH; Wen SW; Zhang YF; Li Y; Cheng JG; Wang GY
Lung; 2015 Aug; 193(4):583-92. PubMed ID: 25851596
[TBL] [Abstract][Full Text] [Related]
2. Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.
Wang J; Song J; Gao Z; Huo X; Zhang Y; Wang W; Qi J; Zheng S
Oncol Rep; 2017 Mar; 37(3):1736-1746. PubMed ID: 28098899
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression changes associated with human carcinoma-associated fibroblasts in non-small cell lung carcinoma.
Wu X; Ruan L; Yang Y; Mei Q
Biol Res; 2017 Feb; 50(1):6. PubMed ID: 28231844
[TBL] [Abstract][Full Text] [Related]
5. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
6. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.
Huang QX; Cui JY; Ma H; Jia XM; Huang FL; Jiang LX
Cancer Gene Ther; 2016; 23(2-3):48-53. PubMed ID: 26679756
[TBL] [Abstract][Full Text] [Related]
7. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
Weng TY; Wang CY; Hung YH; Chen WC; Chen YL; Lai MD
PLoS One; 2016; 11(8):e0161007. PubMed ID: 27513329
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
[TBL] [Abstract][Full Text] [Related]
10. Identification of key differentially expressed genes associated with non‑small cell lung cancer by bioinformatics analyses.
Xiao Y; Feng M; Ran H; Han X; Li X
Mol Med Rep; 2018 May; 17(5):6379-6386. PubMed ID: 29532892
[TBL] [Abstract][Full Text] [Related]
11. Integrating differential pathway analysis with Monte Carlo cross-validation reveals seed cross-talks in non-small cell lung carcinoma.
Zheng ML; Zhou NK; Luo CH
J BUON; 2016; 21(5):1203-1209. PubMed ID: 27837624
[TBL] [Abstract][Full Text] [Related]
12. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
[TBL] [Abstract][Full Text] [Related]
13. Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer.
Tian W; Liu J; Pei B; Wang X; Guo Y; Yuan L
Oncol Rep; 2016 Apr; 35(4):2171-6. PubMed ID: 26781349
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1.
Chen QY; Jiao DM; Wang LF; Wang L; Hu HZ; Song J; Yan J; Wu LJ; Shi JG
Mol Biosyst; 2015 Mar; 11(3):859-68. PubMed ID: 25578635
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.
Du J; Zhang L
Oncol Rep; 2015 Aug; 34(2):585-94. PubMed ID: 26035298
[TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G
Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
Lu C; Chen H; Shan Z; Yang L
Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
[TBL] [Abstract][Full Text] [Related]
19. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
[TBL] [Abstract][Full Text] [Related]
20. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]